COVID-19 in the hotspot of Metropolitan Detroit: A multi-faceted health system experience. 2022

Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
Henry Ford Medical Group Administration, Henry Ford Health System, Detroit, MI, USA.

Health systems were abruptly plunged into a crisis as SARS-CoV-2 exploded into a pandemic in spring 2020. In March-April 2020, Metropolitan Detroit was a US "hotspot." As a large health system with five hospitals and two behavioural health inpatient facilities, a health insurance company, a medical group and physician network, and 41 ambulatory clinics normally hosting over 10,000 daily patient encounters, the Henry Ford Health System deployed numerous strategies in the management of this upheaval. As hospitals and Emergency Departments were inundated with COVID-19 patients, other services and activities needed to shut down as state-mandated policies were promulgated, new internal and external communication networks established, and management of employees and resources such as ventilators, ICU beds, personal protective equipment, and laboratory supplies became critical challenges. We describe herein the system-wide strategies implemented and lessons learned in the operation of a health system in the initial throes of a global pandemic.

UI MeSH Term Description Entries
D012122 Ventilators, Mechanical Mechanical devices used to produce or assist pulmonary ventilation. Mechanical Ventilator,Mechanical Ventilators,Respirators,Ventilators, Pulmonary,Pulmonary Ventilator,Pulmonary Ventilators,Ventilator, Pulmonary,Ventilators,Respirator,Ventilator,Ventilator, Mechanical
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000067393 Personal Protective Equipment Specialized clothing or equipment worn for protection against health hazards. Personal Protective Equipment may include MASKS; RESPIRATORY PROTECTIVE DEVICES; HEAD PROTECTIVE DEVICES; EYE PROTECTIVE DEVICES; EAR PROTECTIVE DEVICES; PROTECTIVE CLOTHING; and protective footwear. PPE Personal Protective Equipment,Equipment, Personal Protective,Personal Protective Equipments,Protective Equipment, Personal
D000086382 COVID-19 A viral disorder generally characterized by high FEVER; COUGH; DYSPNEA; CHILLS; PERSISTENT TREMOR; MUSCLE PAIN; HEADACHE; SORE THROAT; a new loss of taste and/or smell (see AGEUSIA and ANOSMIA) and other symptoms of a VIRAL PNEUMONIA. In severe cases, a myriad of coagulopathy associated symptoms often correlating with COVID-19 severity is seen (e.g., BLOOD COAGULATION; THROMBOSIS; ACUTE RESPIRATORY DISTRESS SYNDROME; SEIZURES; HEART ATTACK; STROKE; multiple CEREBRAL INFARCTIONS; KIDNEY FAILURE; catastrophic ANTIPHOSPHOLIPID ANTIBODY SYNDROME and/or DISSEMINATED INTRAVASCULAR COAGULATION). In younger patients, rare inflammatory syndromes are sometimes associated with COVID-19 (e.g., atypical KAWASAKI SYNDROME; TOXIC SHOCK SYNDROME; pediatric multisystem inflammatory disease; and CYTOKINE STORM SYNDROME). A coronavirus, SARS-CoV-2, in the genus BETACORONAVIRUS is the causative agent. 2019 Novel Coronavirus Disease,2019 Novel Coronavirus Infection,2019-nCoV Disease,2019-nCoV Infection,COVID-19 Pandemic,COVID-19 Pandemics,COVID-19 Virus Disease,COVID-19 Virus Infection,Coronavirus Disease 2019,Coronavirus Disease-19,SARS Coronavirus 2 Infection,SARS-CoV-2 Infection,Severe Acute Respiratory Syndrome Coronavirus 2 Infection,COVID19,2019 nCoV Disease,2019 nCoV Infection,2019-nCoV Diseases,2019-nCoV Infections,COVID 19,COVID 19 Pandemic,COVID 19 Virus Disease,COVID 19 Virus Infection,COVID-19 Virus Diseases,COVID-19 Virus Infections,Coronavirus Disease 19,Disease 2019, Coronavirus,Disease, 2019-nCoV,Disease, COVID-19 Virus,Infection, 2019-nCoV,Infection, COVID-19 Virus,Infection, SARS-CoV-2,Pandemic, COVID-19,SARS CoV 2 Infection,SARS-CoV-2 Infections,Virus Disease, COVID-19,Virus Infection, COVID-19
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic

Related Publications

Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
October 2020, The British journal of surgery,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
May 2021, Journal of general internal medicine,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
June 2020, La Revue de medecine interne,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
May 2022, International journal of STD & AIDS,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
May 2022, Respiratory medicine and research,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
April 2024, Cureus,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
May 2010, Antimicrobial agents and chemotherapy,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
January 2023, JMIR public health and surveillance,
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
January 2023, Work (Reading, Mass.),
Linda Gifford, and Christine C Johnson, and Nadia Haque, and Karla D Passalacqua, and Jennifer Swiderek, and Steven Kalkanis
December 1975, Michigan medicine,
Copied contents to your clipboard!